Navigation Links
Clostridium difficile Infection: Tracking a Virulent Pathogen
Date:8/13/2009

VOORHEES, N.J., Aug. 13 /PRNewswire/ -- The rates and severity of Clostridium difficile infection (CDI) may be impacted by several factors, including antimicrobial use, other drug-prescribing factors, infection control practices, and the presence of a new strain of C. difficile that is more resistant to fluoroquinolones and associated with higher rates of morbidity and mortality. It is crucial for healthcare professionals to be aware of these factors and apply evidence-based practices for the prevention, diagnosis, and treatment of CDI.

To address the need for current education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture entitled Clostridium difficile Infection: Tracking a Virulent Pathogen. The content of this virtual lecture is based on a live symposium that took place on Wednesday, June 10, 2009, during the 36th Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) Annual Conference. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this program are experts in infection control and gastroenterology, including Stuart Johnson, MD, DTM&H; Dale N. Gerding, MD, FACP, FIDSA; Ciaran P. Kelly, MD; and Keith S. Kaye, MD, MPH.

Healthcare professionals can visit www.RMEI.com/CDI079VL to access this complimentary continuing education virtual lecture.

"Robert Michael Educational Institute LLC is committed to providing healthcare professionals with opportunities for quality, innovative, and convenient continuing medical education," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that speciali
'/>"/>

SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
2. Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
3. Transmission of MRSA and Clostridium difficile through dogs
4. Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
5. Interview with GI Experts: Discussions in Clostridium difficile
6. Clostridium difficile Infection: Best Strategies for Care of Older Adults
7. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
8. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
9. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
10. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
11. MRSA and C. difficile Infections Reduced by 50% in Hospital Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...andPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,N...lBipolarFoundationandtheMedicAlertFoundationreceiv...m,whichisnowbeingwidelyacceptedasapreventivehealth...olarFoundationreceivedaproclamationofendorsementvi...isianaMitchLandrieu.TheNationalBipolarFoundationst...
(Date:11/25/2009)...simple question has been the focus of intense rese...lates High Blood Pressure in Mice & Men, Does str... has been the focus of intense research for many y...ablished a link between a novel gene, phosducin, a...s well as humans. The studies were directed by sci...
(Date:11/25/2009)...overlook needed care, study finds , , WE...pression can worsen her child,s asthma, U.S. resea...62 black mothers and their children found that chi...ad more frequent asthma symptoms, while children o...frequent asthma symptoms. , The Johns Hopkins C...
(Date:11/25/2009)...swire/--TheAmericanAssociationforHomecareendorsest...hisdesignedtosubstantiallyimprovetoolsandresources...ucedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMieuxb...forHomecareoutlinedinits13-pointanti-fraudactionpl....Thoseprovisionsincludecallingforreal-timeauditsan...
(Date:11/25/2009)...r in children with autism and related conditions c...medication combined with a structured training pro...earchers and their colleagues. , Published in t...ican Academy of Child and Adolescent Psychiatry , ...of Mental Health (NIMH) Research Units on Pediatri...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Mom's Depression May Worsen Child's Asthma 2Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...pot on Thursday United States fell short of its 20...Listeria by 50 percent.// The statistics relea...ion reveal that the rate of Listeria food poisoni...steria has started to climb because USDA hasn't es...
...pared by health officials in Tripura has brought t...he government// hospital that has claimed the live.... According to the report, submitted to the ...ia, low birth weight, septicemia, malaria, gastro ...
...ealth, John Hatzistergos, has confirmed that a new... a priority basis.// Stating that he has di...tart the detailed planning process for a new hospi...spital that is needed, and where it should be loca...
...tate of Volgograd, in Russia, has reported the dea...o reports from the state veterinary authorities.//...ly 11 regions in Southern Russia have reported Bir...25 hens that died in Volgograd, have tested positi...
...itled ‘Challenging Intellectual Property’ will be ...w York.// The Symposium will look into the a...ciated epitomes of knowledge production in economi... research and development, and enable affordable d...
...hundreds of patients who contracted Hepatitis C in...ing of their condition.// This is same as delayed ...ottish Blood Transfusion Service ,Frank McGuire, a... some had infected their partners. During ...
Other Medicine News:Health News:Government Hospital’s Poor Functioning Claims Lives Of 138 Infant 2Health News:Construction Of A New Hospital In The Bega Area Confirmed 2
(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ...f-carebloodanalysissystems,announcedtodaythatClint...entatthe21stAnnualPiperJaffrayHealthCareConference...cewillbeheldattheNewYorkPalaceHotelinNewYorkCity. ...resandmarketsportablebloodanalysissystemsforuseina...
(Date:11/25/2009)...ov.25/PRNewswire/--CempraPharmaceuticalsInc.todaya...executiveofficer,willpresentatthePiperJaffray21stA...009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernan...tibioticclinicalprogramsforthetreatmentofdrug-resi...rmaceuticals ,, Foundedin2006,CempraPharmaceut...
(Date:11/25/2009)...ndSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareIn...novatorandprovideroflessinvasive,miniaturizedcircu...ntofadvancedheartfailure,todayannouncedthatitissch...iperJaffrayHealthCareConferenceat8:00amESTonWednes...wYorkPalaceHotel,December1-2. ,, Alivewebcastof...
Breaking Medicine Technology:Evolution of a contraceptive for sea lamprey 8994 1Evolution of a contraceptive for sea lamprey 8994 2Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 49989 1Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 49989 2Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 49989 3Statement of Dr Elena Rios MD MSPH President and CEO National Hispanic Medical Association 49986 1
...: The Takeda Oncology,Company today reported the P...pany-sponsored Phase I/II study of VELCADE, dexame... in patients with previously untreated multiple,my... data showed that the,combination of four drugs wa...eived no prior therapies and response rates were e...
...aiichi Sankyo,Company, Limited (TSE: 4568), announ...III trial for DU-176b, an investigational oral Fac...tion. DU-176b is being developed,solely by Daiich...ctive Anticoagulation with Factor Xa Next,Generati...l compare DU-176b,with warfarin in preventing stro...
Other Medicine Technology:Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 2Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 4Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 6Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 2Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 3Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 4